Physician profile
Robert Brookland
NPI 1548261647
$33,747.17
in general payments reported to CMS, 2019-2025
30 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 84% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,833 · 2020: $9,487 · 2021: $4,309 · 2022: $4,294 · 2023: $7,793 · 2024: $1,004 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,480 · Food and Beverage: $2,968 · Travel and Lodging: $258 · Consulting Fee: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,480.00 |
| Food and Beverage | $2,967.64 |
| Travel and Lodging | $257.96 |
| Consulting Fee | $118.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $31,071.26 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $349.35 | 2021-2025 | |
| Boston Scientific Corporation | $326.58 | 2022-2025 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $177.87 | 2022-2024 | Pylarify |
| Sumitomo Pharma America, INC. | $159.00 | 2023-2024 | Orgovyx |
| Teleflex LLC | $138.74 | 2022 | |
| Immunitybio, INC. | $135.18 | 2025 | |
| Merck Sharp & Dohme LLC | $132.54 | 2021-2024 | Keytruda, Lynparza |
| Myovant Sciences INC. | $124.41 | 2022 | |
| Abbvie INC. | $113.73 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $98.51 | 2019-2025 | Provenge |
| Accord Healthcare, INC. | $97.89 | 2024 | |
| Medtronic, INC. | $95.01 | 2023 | Interstim |
| Myriad Genetic Laboratories, INC. | $88.48 | 2022-2024 | Prolaris |
| Palette Life Sciences, INC. | $81.25 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $79.73 | 2019-2023 | Xtandi |
| Urogen Pharma, INC. | $76.05 | 2022 | |
| Telix Pharmaceuticals | $73.48 | 2023 | Illuccix |
| Pfizer INC. | $53.39 | 2022-2023 | |
| Bioprotect Medical, INC. | $47.92 | 2025 | Bioprotect Balloon Implant System |
| Siemens Medical Solutions USA, INC. | $38.79 | 2021-2025 | Bravos Afterloader System |
| Daiichi Sankyo INC. | $29.82 | 2022 | |
| Reflexion Medical, INC. | $27.99 | 2023 | Reflexion Medical Radiotherapy System |
| Janssen Scientific Affairs, LLC | $27.75 | 2019 | |
| Exelixis INC. | $27.13 | 2025 | Cabometyx |
| Elekta, INC. | $25.28 | 2019-2022 | |
| 180 Medical, INC. | $18.17 | 2024 | |
| Blue Earth Diagnostics | $17.19 | 2021 | |
| Janssen Biotech, INC. | $14.68 | 2023 | Erleada |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brookland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.